It is well known that the EBV+ DLBCL have a tolerogenic environment, characterized by the expression of PD1, TIM3, and LAG3 in tumor-infiltrating lymphocytes [10–14], and PDL1 in different types of cells, such as macrophages [14, 28, 29]. This evidence concerns the gene HAVCR2 and diffuse large B-cell lymphoma.